EQS-News: MPH Health Care AG publishes figures for the first half-year of 2025: Equity (NAV) amounts to EUR 205.1 million, which corresponds to EUR 47.91 per share. The equity ratio fell slightly to 93.7%

MPH Health Care AG publishes figures for the first half-year of 2025:

 Equity (net asset value) amounts to EUR 205.1 million, which corresponds to EUR 47.91 per share. The equity ratio fell slightly to 93.7% (31 December 2024: 95.5%)

Berlin, 16^th September 2025 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated results for the first half-year of 2025. Accordingly, equity decreased by 26% from EUR 277.9 million as of 31 December 2024 to EUR 205.1 million as of 30 June 2025. The net asset value (NAV) per share fell from EUR 64.90 (31 December 2024) to EUR 47.91 as of 30 June 2025.

The IFRS result for the period decreased from EUR 74.5 million as of 30 June 2024 to EUR -72.7 million as of 30 June 2025. This result is due to the accounting valuations of the investments as at the reporting date, which do not affect cash flow. MPH AG is an investment company whose investments are reported as financial assets under the balance sheet item ‘Financial investments’ and are measured at fair value through profit or loss on the balance sheet date.

The equity ratio fell slightly from 95.5% to 93.7% and remains at a very high level.

The financial position has improved compared to the previous year. From 1 January to 30 June 2025, an operating cash flow of kEUR 1,016 was generated (previous year: kEUR -895) and a net cash flow of kEUR 261 (previous year: kEUR -2,781).

The fair value losses are mainly due to the sharp decline in the share price of our listed investment CR Energy AG, which unexpectedly filed for (preliminary) insolvency proceedings with the competent local court in Potsdam in June 2025. The price of CR shares fell from EUR 4.78 on 31 December 2024 to EUR 0.54 on 30 June 2025.

The M1 Kliniken AG investment continued its growth trajectory in the first half of 2025, once again increasing both revenue and earnings. IFRS consolidated revenue in the first half of 2025 amounted to EUR 183.5 million, compared with EUR 167.7 million in the first half of 2024. This represents an increase of 9.4%. The Group EBIT margin increased by approximately 14% to 9.8% in the first half of 2025 (same period last year: 8.6%). Operating profit (EBIT) increased to EUR 18.0 million (previous year: EUR 14.5 million). Net profit (before minority interests) as of 30 June 2025 rose by around 19% to EUR 12.5 million.

M1 Kliniken AG continues to grow and aims to increase revenue in the high-margin beauty segment to EUR 200–300 million per year by 2029, with a sustainable EBIT margin of at least 20%. With a dividend payment of EUR 0.50 per share, M1 Kliniken AG is reaffirming its distribution policy.

At this year's Annual General Meeting of MPH Health Care AG on 17 July 2025, it was resolved to distribute a dividend of EUR 1.20 per dividend-bearing share, as in the previous year, and to carry forward the remaining amount of the 2024 net profit of EUR 72.5 million to new account.

The half-yearly report of MPH Health Care AG is available for download under Financial Reports - MPH Health Care AG.

About MPH Health Care AG:

MPH Health Care AG is an investment company with a strategic focus on the acquisition, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. However, MPH also aims to exploit potential opportunities in high-growth and high-yield sectors outside the healthcare market.